Evidence map›Paper›PMID 31450834›Full record

ArticleInternational journal of molecular sciences2019

Modulation of Cardiovascular Function in Primary Hypertension in Rat by SKA-31, an Activator of

Monika Kloza, Marta Baranowska-Kuczko, Marek Toczek, Magdalena Kusaczuk, Olga Sadowska, Irena Kasacka, Hanna Kozłowska

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Monika KlozaDepartment of Experimental Physiology and Pathophysiology, Medical University of Białystok, 15-222 Białystok, Poland.
Marta Baranowska-KuczkoDepartment of Experimental Physiology and Pathophysiology, Medical University of Białystok, 15-222 Białystok, Poland.
Marek ToczekDepartment of Experimental Physiology and Pathophysiology, Medical University of Białystok, 15-222 Białystok, Poland.
Magdalena KusaczukDepartment of Pharmaceutical Biochemistry, Medical University of Białystok, 15-222 Białystok, Poland.
Olga SadowskaDepartment of Experimental Physiology and Pathophysiology, Medical University of Białystok, 15-222 Białystok, Poland.
Irena KasackaDepartment of Histology and Cytophysiology, Medical University of Białystok, 15-222 Białystok, Poland.
Hanna KozłowskaDepartment of Experimental Physiology and Pathophysiology, Medical University of Białystok, 15-222 Białystok, Poland. hkozl@umb.edu.pl.
Medical University of Białystok · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this study was to investigate the hemodynamic effects of SKA-31, an activator of the small (

Indexed as

AnimalsBenzothiazolesBlood PressureCardiovascular SystemDisease Models, AnimalEndothelium, VascularEssential HypertensionIntermediate-Conductance Calcium-Activated Potassium ChannelsRatsRats, Inbred SHRSmall-Conductance Calcium-Activated Potassium ChannelsBenzothiazolesIntermediate-Conductance Calcium-Activated Potassium ChannelsKcnn4 protein, ratnaphtho(1,2-d)thiazol-2-ylamineSmall-Conductance Calcium-Activated Potassium ChannelshypertensionKCa3.1/KCa2.3-EDH–dilator systemKIRNa+/K+-ATP-aseSHRSKA-31

Identifiers

PMID31450834
PMCPMC6747311
OpenAlexW2969366482

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.